ASL Human

Argininosuccinate Lyase Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to Argininosuccinate Lyase (ASL) in Humans

Argininosuccinate Lyase (ASL) is a critical enzyme in the urea cycle and arginine biosynthesis, encoded by the ASL gene located on chromosome 7q11.21 . It catalyzes the cleavage of argininosuccinate into arginine and fumarate, enabling nitrogen excretion and endogenous arginine production . ASL deficiency (ASLD) disrupts these processes, leading to hyperammonemia, neurocognitive impairments, and multi-organ dysfunction .

Key Functions of ASL

  • Urea Cycle: Converts argininosuccinate to arginine, facilitating ammonia detoxification .

  • Arginine Biosynthesis: Sole enzyme producing arginine, a precursor for nitric oxide (NO), polyamines, and creatine .

Metabolic Impact of ASL Deficiency

Biochemical MarkerTypical Levels in ASLDClinical Significance
Plasma citrulline100–300 μmol/LIndicates urea cycle disruption
Urine argininosuccinic acid>10,000 μmol/g creatinineHallmark of ASLD
Plasma ammoniaElevated during crisesCauses neurotoxicity

ASL Gene Structure

  • Exons: 17 exons spanning ~17 kb .

  • Expression: Liver, kidney, brain, and endothelial cells .

Pathogenic Variants in ASLD

MutationTypeFunctional ImpactSource
c.206A>G (p.Lys69Arg)MissenseReduced enzyme activity
c.637C>T (p.Arg213∗)NonsenseNo detectable activity
c.434A>GMissenseImpaired tetramer stability

Phenotypic Spectrum

  • Acute Symptoms: Hyperammonemia, seizures, respiratory alkalosis .

  • Chronic Manifestations: Hypertension, hepatic fibrosis, intellectual disability .

Neurovascular Dysfunction

ASL-deficient endothelial cells exhibit disrupted blood-brain barrier (BBB) integrity due to NO deficiency :

  • Transendothelial Electrical Resistance (TEER): Reduced by 40% in ASL-knockdown HBMECs .

  • Rescue Mechanisms: NO donors (e.g., L-arginine) partially restore BBB function .

ASL Tetramer Dynamics

  • Quaternary Structure: Homotetramer (4 × 52 kDa subunits) with cooperative substrate binding .

  • Active Site: Binds adenylosuccinate analogs (e.g., APBADP) competitively (K<sub>I</sub> = 0.1 μM) .

Mutant Enzyme Activity

Mutation (B. subtilis/Human)Residual Activity (% of WT)Substrate Affinity (K<sub>m</sub>)
S262A/S263A (B. subtilis)<1%Unchanged
S289A/S290A (Human)12.5%Increased

Current Treatments

  • Arginine Supplementation: Restores arginine pools but fails to address NO deficiency .

  • NO Donors: Improve endothelial function in preclinical models .

Experimental Approaches

  • Gene Therapy: Preclinical trials targeting ASL mutations .

  • Metabolite Channeling: Enhancing ASL’s structural role in NO synthesis .

Product Specs

Introduction
Argininosuccinate lyase (ASL) is a member of the lyase 1 family. It is an enzyme that catalyzes the reversible breakdown of argininosuccinate (ASA) into the amino acids arginine and fumarate. ASL, found in the cytosol of liver cells, is the fourth enzyme in the urea cycle. It plays a crucial role in arginine biosynthesis in all species and urea production in ureotelic species. While argininosuccinate synthetase (ASS) catalyzes the formation of argininosuccinate from citrulline and aspartate, ASL breaks down the newly formed argininosuccinate into L-arginine and fumarate. L-arginine continues within the urea cycle to form urea and ornithine, while fumarate can enter the citric acid cycle. Mutations in the ASL gene can lead to argininosuccinic aciduria, an autosomal recessive disorder characterized by argininosuccinic acid lyase deficiency.
Description
Recombinant human ASL, produced in E. coli, is a single, non-glycosylated polypeptide chain containing 484 amino acids (amino acids 1-464) with a molecular weight of 53.8 kDa. It includes a 20-amino acid His-tag fused at the N-terminus. The protein is purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The ASL solution is provided at a concentration of 0.5 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 2 mM DTT, 10% glycerol, and 100 mM NaCl.
Stability
NPL Human Recombinant, while stable for one week at 4 degrees Celsius, should be stored at -18 degrees Celsius or lower for optimal long-term storage. The addition of a carrier protein (0.1% HSA or BSA) is recommended for extended storage. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 95% using SDS-PAGE analysis.
Synonyms
Argininosuccinate lyase, ASAL, Arginosuccinase, ASL.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MASESGKLWG GRFVGAVDPI MEKFNASIAY DRHLWEVDVQ GSKAYSRGLE KAGLLTKAEM DQILHGLDKV AEEWAQGTFK LNSNDEDIHT ANERRLKELI GATAGKLHTG RSRNDQVVTD LRLWMRQTCS TLSGLLWELI RTMVDRAEAE RDVLFPGYTH LQRAQPIRWS HWILSHAVAL TRDSERLLEV RKRINVLPLG SGAIAGNPLG VDRELLRAEL NFGAITLNSM DATSERDFVA EFLFWASLCM THLSRMAEDL ILYCTKEFSF VQLSDAYSTG SSLMPQKKNP DSLELIRSKA GRVFGRCAGL LMTLKGLPST YNKDLQEDKE AVFEVSDTMS AVLQVATGVI STLQIHQENM GQALSPDMLA TDLAYYLVRK GMPFRQAHEA SGKAVFMAET KGVALNQLSL QELQTISPLF SGDVICVWDY GHSVEQYGAL GGTARSSVDW QIRQVRALLQ AQQA.

Q&A

What is American Sign Language and how does it compare structurally to spoken languages?

American Sign Language (ASL) is a complete, natural language with its own linguistic properties distinct from English. While often misconceived as simply a manual representation of English, ASL is expressed through movements of the hands and face and possesses unique grammatical structures .

From a linguistic perspective, ASL contains all fundamental features of language including:

  • Distinct rules for pronunciation (expressed through hand configurations and movements)

  • Specific word formation patterns

  • Unique syntactic structures and word order rules

Unlike English, which signals questions through pitch modulation and word order adjustments, ASL users ask questions by raising their eyebrows, widening their eyes, and tilting their bodies forward . This demonstrates how ASL employs entirely different modalities to fulfill the same linguistic functions as spoken languages.

Regional variations in ASL exist, comparable to dialectal differences in spoken languages. These variations manifest in signing rhythm, pronunciation, slang, and the specific signs used. As with spoken languages, sociological factors such as age and gender also influence ASL usage patterns .

How do researchers study ASL acquisition in different populations?

Research into ASL acquisition follows several methodological approaches depending on the population being studied:

For deaf children with deaf parents (native signers):

  • Longitudinal observational studies tracing natural language development

  • Video recording and analysis of parent-child sign interactions

  • Milestone comparison with spoken language acquisition timelines

For deaf children with hearing parents:

  • Comparative analysis between early and late ASL exposure

  • Assessment of language fluency development through peer interactions

  • Intervention studies examining different teaching methodologies

Research methodologies typically include:

  • Video analysis with specialized coding systems for tracking sign acquisition

  • Experimental tasks measuring comprehension and production

  • Eye-tracking studies to measure visual attention during signing

The National Institute on Deafness and Other Communication Disorders (NIDCD) supports research specifically focused on understanding the acquisition and developmental trajectory of sign language . These studies reveal that deaf children with deaf parents who use ASL acquire language following developmental patterns similar to hearing children learning spoken languages, suggesting universal principles in human language acquisition regardless of modality.

What are the fundamental research parameters for studying ASL as a linguistic system?

When studying ASL as a complete linguistic system, researchers typically focus on the following fundamental parameters:

ParameterDescriptionResearch Methods
PhonologyHand shapes, movements, locations, and non-manual markersMotion capture, video analysis, contrast pair testing
MorphologyHow signs combine to create meaningCorpus analysis, elicitation tasks
SyntaxRules governing sign order and sentence structureGrammaticality judgment tasks, narrative analysis
PragmaticsSocial use of language in contextDiscourse analysis, conversational interaction studies
Regional VariationDialectal differences across geographic regionsComparative studies, linguistic atlas creation

Research methodologies must account for the three-dimensional nature of sign languages and typically employ specialized annotation software such as ELAN to code for multiple simultaneous linguistic features. Unlike research on spoken languages, ASL research requires capturing and analyzing both manual components (handshapes, movements) and non-manual components (facial expressions, body posture) simultaneously .

How do neurobiological research methods illuminate the cognitive processing of ASL?

Advanced neuroimaging techniques have revolutionized our understanding of how the brain processes sign language. Current research methodologies include:

Event-Related Potential (ERP) studies measure brain electrical activity in response to specific linguistic stimuli. Research has shown that semantic violations in ASL produce the same N400 effect seen in spoken language processing, suggesting similar underlying neural mechanisms for meaning extraction regardless of language modality.

Research has revealed that the building of complex phrases, whether signed or spoken, engages the same brain areas, suggesting modality-independent language processing systems . These findings provide critical insights for:

  • Developing treatment approaches for language system injuries

  • Employing signs or gestures in therapy for both children and adults

  • Improving diagnostic criteria for language impairment in deaf individuals

Researchers must carefully control for variables such as age of acquisition, language proficiency, and potential bilingualism effects when studying the neurobiology of ASL processing.

What methodological approaches are most effective for analyzing emerging sign languages and their implications for language universals?

Emerging sign languages provide unique "natural laboratories" for understanding language creation and evolution. The NIDCD funds research specifically examining sign languages that have developed in small communities with little outside influence . Effective methodological approaches include:

  • Longitudinal documentation of language development across generations

  • Comparative analysis between different emerging sign languages

  • Micro-genetic analysis of novel grammatical features

  • Network analysis of language transmission patterns

These methodologies help researchers model the essential elements and organization of natural language and examine the complex interactions between:

  • Innate human language capabilities

  • Environmental language context

  • Language learning outcomes

When studying emerging sign languages, researchers must employ rigorous documentation practices including multi-angle video recording, detailed transcription systems, and careful metadata collection. Ethical considerations include ensuring community ownership of language data and implementing appropriate informed consent procedures that respect deaf cultural norms.

How do researchers address the methodological challenges in studying the interaction between ASL and English in bilingual contexts?

Studying ASL-English bilingualism presents unique methodological challenges requiring specialized approaches:

Code-blending analysis: Unlike spoken language bilingualism where code-switching occurs sequentially, sign-spoken language bilinguals may produce simultaneous signs and words, requiring complex multi-modal analysis techniques.

Cross-modal transfer effects: Researchers must develop specialized tasks to examine how grammatical knowledge transfers between visual-spatial (ASL) and auditory-vocal (English) modalities.

Educational context variables: Studies must account for the wide variation in educational approaches (ASL-only, English-only, bilingual) and their effects on language development.

Methodological solutions include:

  • Development of standardized assessment tools validly measuring ASL proficiency

  • Creation of matched stimuli sets across languages

  • Implementation of eye-tracking to measure visual attention allocation between signing and text/captions

  • Use of mixed-methods approaches combining quantitative language measures with qualitative interviews and observations

The design of studies examining ASL-English bilingualism must carefully control for factors such as age of acquisition of each language, language dominance, family language background, and educational history to produce valid results.

What is the fundamental structure and function of human Adenylosuccinate Lyase (ASL)?

Adenylosuccinate Lyase (ASL) is a critical enzyme in human metabolism that catalyzes two reactions in the purine nucleotide cycle:

  • The conversion of adenylosuccinate to adenosine monophosphate (AMP) and fumarate

  • The conversion of succinylaminoimidazole carboxamide ribotide (SAICAR) to aminoimidazole carboxamide ribotide (AICAR) and fumarate

The enzyme functions as a homotetramer, meaning it consists of four identical subunits that work together . Mutations in the ASL gene can lead to ASL deficiency, a rare inherited metabolic disorder affecting the urea cycle, leading to the accumulation of toxic substances in the body.

Research methodologies for studying ASL structure typically include:

  • X-ray crystallography to determine three-dimensional protein structure

  • Site-directed mutagenesis to analyze the function of specific amino acid residues

  • Enzyme kinetics studies to measure reaction rates and substrate binding

These approaches have revealed critical information about the enzyme's active site, substrate binding pockets, and the conformational changes that occur during catalysis.

What genetic and biochemical methods are used to identify ASL mutations in clinical research?

Clinical research on ASL deficiency employs several complementary genetic and biochemical approaches:

Next-Generation Sequencing (NGS): This has become a primary method for detecting mutations in the ASL gene. Studies have demonstrated that NGS can identify both common and novel mutations, including compound heterozygous mutations where each gene carries a mutation inherited from one parent .

Biochemical analysis: Clinical diagnosis is confirmed by measuring ammonia and argininosuccinate levels in plasma. Elevated levels of these compounds suggest ASL deficiency .

Genetic techniques include:

  • Targeted gene sequencing of the ASL gene

  • Whole exome sequencing when targeted approaches are inconclusive

  • MLPA (Multiplex Ligation-dependent Probe Amplification) to detect large deletions or duplications

  • RNA analysis to identify splicing defects, particularly involving exons 2 and 7, which are known to be alternatively spliced

Research has revealed that most ASL deficient patients are compound heterozygotes, with each gene carrying a different mutation inherited from one parent . This genetic complexity necessitates comprehensive genetic analysis approaches.

What are the established experimental models for studying ASL function and deficiency?

Researchers employ various experimental models to study ASL function and deficiency:

Model SystemApplicationsAdvantagesLimitations
In vitro enzyme assaysKinetic studies, substrate specificityPrecise control of reaction conditionsLacks cellular context
Purified recombinant proteinsStructure-function relationshipsAllows study of specific mutationsMay not reflect in vivo behavior
Cell culture systemsExpression studies, rescue experimentsCellular environment, easier manipulationLimited tissue-specific factors
Animal models (mice, zebrafish)Systemic effects, development, behaviorWhole organism effectsSpecies differences
Patient-derived cellsDisease-relevant phenotypesDirect human relevanceLimited availability, heterogeneity

For in vitro studies, researchers have developed methods to generate hybrid ASL tetramers that mimic the compound heterozygote state found in many patients. This involves denaturing pairs of enzymes in guanidinium chloride and then renaturing them by removing the denaturant . These hybrid enzymes can then be separated using affinity chromatography based on histidine tags, allowing the study of interactions between wild-type and mutant subunits.

What methodological approaches best characterize the molecular interactions in ASL hybrid enzymes?

Advanced research on ASL hybrid enzymes employs sophisticated biochemical and biophysical techniques to understand molecular interactions:

Analytical ultracentrifugation data has been used to demonstrate that in vitro generated hybrids predominantly contain heterotetramers rather than homotetramers, validating their use as models for studying compound heterozygote scenarios . Researchers analyze the maximum velocity (Vmax) values of these hybrids to determine whether subunits function independently or exhibit cooperative behaviors.

Studies have revealed that most ASL subunits behave independently within hybrid tetramers, but still retain weak positive cooperativity, indicating some interaction between different subunit types . These interactions may be advantageous in certain contexts:

  • In parents of ASL deficient patients, interactions between wild-type and mutant subunits may maintain sufficient enzyme function

  • In heterozygote ASL deficient patients, interactions between certain mutant subunits may partially compensate for loss of function

Methodological considerations for studying these molecular interactions include:

  • Careful design of tagged and untagged protein constructs

  • Optimization of denaturation and renaturation conditions

  • Precise kinetic measurements under physiologically relevant conditions

  • Controls to ensure proper folding and oligomerization

How do researchers effectively analyze the complex relationship between ASL genotype and clinical phenotype?

The relationship between ASL mutations and clinical manifestations is complex and requires sophisticated analytical approaches:

Genotype-phenotype correlation studies: Researchers collect comprehensive genetic data and detailed clinical information from patients to identify patterns. This requires:

  • Standardized clinical assessment protocols

  • Complete genetic characterization including intronic and regulatory regions

  • Statistical methods suitable for rare diseases with limited patient numbers

Functional characterization of mutations: Each mutation's impact on enzyme function must be assessed through:

  • In vitro expression studies measuring residual enzyme activity

  • Protein stability and folding analyses

  • Subcellular localization studies

  • Examination of effects on protein-protein interactions

Systems biology approaches: These integrate multiple data types to understand the broader metabolic consequences:

  • Metabolomics to identify biomarkers associated with specific mutations

  • Computational modeling of metabolic pathways affected by ASL deficiency

  • Transcriptomics to identify compensatory mechanisms

Research has shown that the clinical presentation of ASL deficiency varies significantly, with both severe neonatal forms and milder late-onset forms . Understanding the molecular basis for this phenotypic variability requires integration of data across multiple biological levels.

What emerging technologies are advancing the detection and characterization of novel ASL mutations?

Cutting-edge technologies are transforming our ability to detect and characterize ASL mutations:

Long-read sequencing technologies (Oxford Nanopore, PacBio) allow researchers to sequence entire genes in single reads, improving detection of structural variants and complex rearrangements that may be missed by short-read technologies.

CRISPR-based functional screens enable systematic assessment of the functional impact of thousands of potential mutations, helping prioritize variants of uncertain significance discovered in patients.

Cryo-electron microscopy (Cryo-EM) provides high-resolution structural information about wild-type and mutant ASL proteins, revealing how specific mutations affect protein conformation and oligomerization.

Protein stability assays such as differential scanning fluorimetry and hydrogen-deuterium exchange mass spectrometry offer insights into how mutations affect protein folding and dynamics.

High-throughput enzymatic assays coupled with machine learning approaches allow researchers to predict the functional consequences of novel mutations based on their biochemical signatures.

These technologies have revealed that mutations can affect ASL function through multiple mechanisms including altered catalytic activity, reduced protein stability, impaired oligomerization, or aberrant subcellular localization. In ASAuria (argininosuccinic aciduria), next-generation sequencing has successfully detected mutations like D145G, confirming clinical diagnoses of the disorder .

How do research methodologies differ when studying ASL as a language versus ASL as an enzyme?

The dual meaning of the acronym "ASL" presents an interesting case study in methodological divergence across scientific disciplines:

Research AspectAmerican Sign LanguageAdenylosuccinate Lyase
Primary disciplinesLinguistics, Cognitive Science, EducationBiochemistry, Genetics, Medicine
Research subjectsHuman participants (signers)Proteins, cells, animal models, patients
Data collectionVideo recording, motion capture, interviewsSpectrophotometry, chromatography, genetic sequencing
Ethical considerationsCultural sensitivity, community involvementPatient privacy, genetic counseling implications
Analytical approachesLinguistic analysis, statistical models of usageEnzyme kinetics, structural biology, mutation analysis

While these research areas appear distinct, cross-disciplinary approaches can be valuable. For example, research on how ASL (the language) is processed in the brain can inform broader questions of neural plasticity that may be relevant to understanding compensatory mechanisms in patients with ASL (the enzyme) deficiency.

Methodological rigor in both fields requires:

  • Clear operational definitions

  • Appropriate controls

  • Recognition of limitations

  • Awareness of potential biases

What are the methodological considerations for studying how ASL deficiency impacts language development?

This interdisciplinary research question bridges biochemistry and linguistics:

ASL deficiency (Adenylosuccinate Lyase) can lead to neurological symptoms including intellectual disability, which may impact language acquisition and development. Research examining this connection requires:

Comprehensive assessment protocols:

  • Standardized language assessments (both receptive and expressive)

  • Cognitive testing sensitive to subtle deficits

  • Careful documentation of language exposure and environment

Longitudinal study designs tracking development over time to distinguish between delayed versus deviant language trajectories.

Control matching considerations:

  • Age and general cognitive functioning

  • Socioeconomic status and educational opportunities

  • For multilingual participants, matching language exposure patterns

Specialized assessment for sign language when studying deaf children with ASL deficiency, requiring evaluators fluent in sign language and familiar with typical acquisition patterns.

This research area remains relatively unexplored but offers potential insights into both the neurobiological basis of language and the cognitive effects of metabolic disorders.

What are the most promising future research directions at the intersection of ASL research domains?

Despite the distinct nature of these research areas, several promising future directions emerge:

  • Advances in neuroimaging techniques will allow more precise mapping of brain regions involved in both sign language processing and the neurological effects of metabolic disorders like ASL deficiency.

  • Gene therapy approaches for ASL deficiency may benefit from understanding how the brain adapts to different language modalities, potentially informing rehabilitation strategies.

  • Big data approaches in both fields:

    • Large-scale sign language corpora will improve our understanding of ASL linguistics

    • Comprehensive genetic and clinical databases will enhance our ability to predict ASL deficiency phenotypes

  • Technological innovations such as advanced motion capture for sign language analysis and rapid genetic sequencing for metabolic disorders will accelerate research progress in both domains.

  • Early intervention programs for both deaf children learning ASL and children with ASL deficiency may share methodological approaches for assessing developmental outcomes.

The study of both ASL domains ultimately contributes to our understanding of human biology—whether through language as a unique human cognitive capacity or through the essential metabolic pathways that support human development and function.

How can researchers effectively communicate across disciplinary boundaries when discussing ASL research?

Effective cross-disciplinary communication requires clarity and precision:

  • Clear terminology: Always provide the full term (American Sign Language or Adenylosuccinate Lyase) upon first mention, rather than relying solely on the acronym.

  • Contextual framing: Begin presentations or papers with explicit statements about which ASL domain is being discussed.

  • Visual distinction: In written materials, consider using different formatting for the acronym when referring to different domains.

  • Interdisciplinary collaboration: Research teams spanning both domains should develop shared vocabularies and understanding of methodological approaches.

  • Specialized publication venues: Consider journals that explicitly welcome interdisciplinary research to reach audiences familiar with both domains.

By adopting these practices, researchers can avoid confusion and potentially identify unexpected connections between these distinct research areas.

Product Science Overview

Introduction

Argininosuccinate lyase (ASL) is a crucial enzyme in the urea cycle, responsible for catalyzing the reversible breakdown of argininosuccinate into fumarate and L-arginine . This enzyme plays a vital role in the biosynthesis of arginine and the production of urea in ureotelic species . The human recombinant form of this enzyme is produced using recombinant DNA technology, which allows for the expression of the human ASL gene in a host organism, typically bacteria or yeast.

Structure and Function

ASL is composed of four identical monomers, each consisting of a single polypeptide chain with a molecular weight between 49 and 52 kDa . The entire tetrameric enzyme has a molecular weight between 196 and 208 kDa . Each monomer contains three highly conserved regions that cluster together in the tetramer to form four active sites, allowing for the catalytic activity at each possible active site .

The enzyme’s cleavage of argininosuccinate to form fumarate and arginine occurs through an E1cb elimination reaction . This reaction is initiated by the deprotonation of the carbon adjacent to the arginine, leading to the formation of the products .

Genetic Basis and Mutations

The ASL gene is located on chromosome 7 between the centromere and the long (q) arm at position 11.2 . Mutations in the ASL gene can lead to argininosuccinic aciduria, a rare autosomal recessive disorder characterized by deficiencies in the urea cycle . This condition results in the accumulation of argininosuccinate in the body, leading to various clinical symptoms .

Preparation Methods

The preparation of human recombinant ASL involves the insertion of the human ASL gene into a suitable expression vector, which is then introduced into a host organism such as Escherichia coli or Saccharomyces cerevisiae . The host organism expresses the ASL protein, which is subsequently purified using techniques such as affinity chromatography . The recombinant enzyme can then be used for various research and therapeutic applications.

Chemical Reactions

ASL catalyzes the reversible breakdown of argininosuccinate into fumarate and L-arginine . This reaction is a key step in the urea cycle, which is the major pathway for the detoxification of ammonia in the body . The enzyme’s activity is essential for the continuation of the urea cycle and the production of arginine, which is a precursor for the synthesis of proteins, nitric oxide, and other important molecules .

Clinical Significance

Deficiencies in ASL activity due to genetic mutations can lead to argininosuccinic aciduria, which is associated with hyperammonemia, developmental delay, and other neurological symptoms . Early diagnosis and treatment are crucial for managing this condition and preventing severe complications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.